Dendreon Corp. (Nasdaq: DNDN) swung to a profit for the fourth quarter of 26 cents per share compared with a loss of 64 cents per share in the year ago period but warned of significant charges in the first quarter and forecast lower than expected sales of Provenge in the first quarter. Shares of the biotechnology company planed $2.91 to $11.95.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here